Labcorp LH

Labcorp Holdings Inc. · NYSE · Services-Medical Laboratories

$360.25+8.78%close on Oct. 28, 2026 · volume 1.8M · Yahoo Finance

Price, last 47 sessions

$320.00$340.00$360.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $360.25 · low $303.98 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 17, 2026Kerrii B. Anderson
director
Sold
10b5-1 plan
3,000$318.02$954,060
Aug. 11, 2026Adam H. Schechter
President & CEO, director
Sold
10b5-1 plan
4,669$320.37$1.50 million
Aug. 4, 2026Amy B. Summy
EVP, Chief Marketing Officer
Sold924$306.74$283,428
Aug. 3, 2026Peter J. Wilkinson
SVP, Chief Accounting Officer
Sold1,420$309.23
$309.22-$309.23
$439,107

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 18 →
  • 8-KOct. 28, 2026, 6:57 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedLabcorp beats Q3 2026 adjusted EPS consensus with $4.78 vs $4.64 and raises full-year adjusted EPS guidance to $18.30-$18.70

  • 8-KOct. 21, 2026, 6:51 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedLabcorp Holdings Declares $0.72 Quarterly Cash Dividend Payable December 11, 2026

  • 8-KSept. 30, 2026, 8:32 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 8-KSept. 22, 2026, 4:43 p.m. ETView on SEC.gov

    Regulation FD disclosure

  • 8-KSept. 10, 2026, 4:47 p.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 4Sept. 3, 2026, 8:21 a.m. ETView on SEC.gov
  • 4Sept. 3, 2026, 8:19 a.m. ETView on SEC.gov
  • 4Sept. 3, 2026, 8:18 a.m. ETView on SEC.gov